Cipla EU to Invest EUR 15 million in Ethris
Cipla & Ethris partner for the development of mRNA-based therapies
02-Jan-2023 -
Cipla Limited announced that its wholly owned UK subsidiary, Cipla (EU) Limited has signed definitive agreements for equity investment of EUR 15 million in Ethris GmbH, a global leader in delivering mRNAs directly to the respiratory system including administration by inhalation.
The investment ...
investments
mRNA therapies